{{Rsnum
|rsid=1870050
|Gene=GLDN
|Chromosome=15
|position=51344354
|Orientation=plus
|GMAF=0.1056
|Gene_s=GLDN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 83.1 | 15.4 | 1.5
| HCB | 66.7 | 20.0 | 13.3
| JPT | 62.8 | 25.6 | 11.6
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 66.7 | 20.0 | 13.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24324964
|Title=CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer
|OA=1
}}{{PMID Auto
|PMID=17507620
|Title=Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
}}

{{PMID Auto
|PMID=17827443
|Title=Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.
|OA=1
}}